echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > 9 latest endocrinology guidelines/consensus/expert interpretations, one article included in the bag|Guideline consensus

    9 latest endocrinology guidelines/consensus/expert interpretations, one article included in the bag|Guideline consensus

    • Last Update: 2021-03-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Edited by Yimaitong, please do not reprint without authorization.

    Guide: This article summarizes the guidelines/consensus/expert interpretations of endocrinology diseases released in February 2021 for everyone to read and download.

     Interpretation of the "2021 American Diabetes Association Diabetes Medical Diagnosis and Treatment Standards" With the continuous emergence of new technologies, new therapies and related evidence-based evidence, the field of diabetes management has undergone rapid changes in recent years.

    Since its first release in 1989, the "Standards for Diabetes Medical Diagnosis and Treatment" formulated by the American Diabetes Association (ADA) covers the latest changes in diabetes diagnosis and treatment, and has become one of the authoritative guidelines for clinical practice of diabetes management.

    Recently, the ADA updated the guidelines based on the latest evidence-based evidence, and published the "2021 ADA Diabetes Medical Diagnosis and Treatment Standards" in the Diabetes Care supplement, which aims to provide clinicians, researchers and patients with diabetes management elements and treatment goals And diagnosis and treatment quality assessment tools.

    This article interprets the hot issues and important updates.

     Download link: http://guide.
    medlive.
    cn/guidelinesub/8194 Cardiovascular risk assessment of type 2 diabetes and selection of hypoglycemic drugs for prevention and treatment of cardiovascular disease-interpretation of "2019ESC/EASD Guidelines for Diabetes, Prediabetes and Cardiovascular Diseases" In August 2019, the European Society of Cardiology (ESC) and the European Society for the Study of Diabetes (EASD) issued the third edition of the Cardiovascular Disease (CVD) Prevention and Treatment Guidelines for people with diabetes (DM) and pre-DM.

    Although the time interval is not long since the previous edition was released in 2013, there have been endless researches on cardiovascular events in type 2 diabetes (T2D) in recent years, and there is definite evidence that some hypoglycemic drugs have cardiovascular benefits other than hypoglycemic drugs.
    Therefore, it is worth promoting and applying these research results to clinical practice as soon as possible.Due to the large content of this edition of the guide, this article focuses on sharing the relevant parts of T2D cardiovascular risk assessment and the selection of hypoglycemic drugs for the prevention and treatment of CVD that are closely related to endocrinologists.

     Download link: http://guide.
    medlive.
    cn/guidelinesub/8167 2021 Asian expert advice: use sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease to release early release of type 2 diabetes and high incidence of comorbidities The higher the risk of diabetic nephropathy (DKD) and the risk of rapid progression in Asian populations.

    In addition to inhibitors of the renin-angiotensin system, sodium-glucose cotransporter 2 inhibitors have also been proven to delay the progression of DKD.

    This article mainly relates to the application of sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease, and points out that SGLT-2 inhibitors can delay the disease progression of Asian DKD patients and protect the renal function of patients at high risk of kidney disease.

    Download link: http://guide.
    medlive.
    cn/guideline/22787 American Diabetes Association 2021 "Guidelines for Diagnosis and Treatment of Diabetes in Pregnancy" Introduction In December 2020, the American Diabetes Association (ADA) updated and released based on the latest evidence-based medical evidence 2021 "Guidelines for Diagnosis and Treatment of Diabetes".

    The guidelines are published in the Diabetes Care magazine and include guidelines for the diagnosis and treatment of diabetes mellitus in pregnancy.

    Compared with the guidelines published in 2020, the guidelines of 2021 on the management of pregnancy complicated with diabetes [pre-pregnancy type 1 diabetes (T1DM) and type 2 diabetes (T2DM)], preeclampsia and aspirin, drug use during pregnancy, and postpartum health care and follow-up Part of the content has been updated and supplemented.

    Regarding pre-pregnancy counseling and health care, blood glucose control goals during pregnancy, and gestational diabetes (GDM) management, the 2021 guidelines are basically consistent with the 2020 guidelines.

    This article introduces the updated content of gestational diabetes in the 2021 guideline compared with 2020, in order to provide a reference for clinical practice.

     Download link: http://guide.
    medlive.
    cn/guidelinesub/8197 Canadian Association of Obstetricians and Gynecologists "Guidelines for Gestational Diabetes (2019)" Interpretation of the main points of the gestational diabetes (GDM) incidence has increased year by year in recent years.
    The Canadian study found that, In 10 years, the incidence of GDM and pre-gestational diabetes (including type 1 and type 2 diabetes) increased from 2.
    7% and 0.
    7% to 5.
    6% and 1.
    5%, respectively.

    In 2014, the incidence of GDM in my country was as high as 18.
    9%.

    GDM leads to an increased risk of adverse maternal and infant outcomes (shoulder dystocia, cesarean section, infants older than gestational age, premature delivery, and severe neonatal deformities).

    In 2019, the Society of Obstetricians and Gynecologists of Canada (SOGC) updated the GDM clinical guidelines, reviewed the evidence related to GDM diagnosis and obstetric management, and evaluated the short-term and long-term effects on pregnant women and fetuses.

    This article explains the main points of the guide.

     Download link: http://guide.
    medlive.
    cn/guidelinesub/8173 Expert consensus on blood pressure management for adult diabetic patients Diabetes and hypertension are two high-incidence diseases that seriously endanger people's health, and they often coexist.

    Managing the blood pressure of diabetic patients is an important measure to prevent and delay the complications of diabetes.
    It is of great significance to reduce the burden of diabetes and hypertension.
    However, the current blood pressure control status of diabetic patients in my country is not ideal.

    In recent years, new evidence-based medical evidence in the field of diabetes and hypertension has continued to emerge, and guidelines for diabetes and hypertension at home and abroad have been updated from time to time.
    In particular, SGLT-2 inhibitors have a good blood pressure lowering effect and are beneficial to the blood pressure management of diabetic patients.
    Impact.

    In view of this, the Diabetes Branch of the Shanghai Medical Association and the Endocrinology Branch of the Shanghai Medical Association organized experts to analyze and sort out the relevant clinical evidence and form a consensus on blood pressure management in adult diabetic patients.

    Recommended reading: How to manage blood pressure in diabetic patients? The latest consensus says so.
    Download link: http://guide.
    medlive.
    cn/guideline/22637 Adult perioperative blood glucose monitoring Expert consensus on perioperative blood glucose management is very important.

    Accurate, fast and convenient blood glucose monitoring methods and practical monitoring programs are the prerequisites for effective management of perioperative blood glucose.

    In order to obtain satisfactory blood glucose management for patients during perioperative period, it is very important to regulate the scope of blood glucose monitoring program during operation.

    Based on the latest evidence-based medical evidence and the clinical practice of DM prevention and treatment in my country, the Nursing Branch of the Chinese Research Hospital Association cooperates with the Beijing Society of Perioperative Medicine, the Diabetes Committee of the Chinese Research Hospital Association, the Diabetes Nursing Committee of the Chinese Nursing Society, and China Nursing The Society of Surgical Nursing Special Committee organizes multidisciplinary medical experts to compile this consensus, hoping to provide clinical guidance and practical adult perioperative blood glucose monitoring programs.

    Recommended reading: What should be paid attention to in blood glucose monitoring during perioperative period? The latest expert consensus is here! Download link: http://guide.
    medlive.
    cn/guideline/22748 Menopausal Women’s Health Management Expert Consensus (basic level version) is to standardize the health management of menopausal women in primary medical institutions, early identification of menopausal related issues and active intervention to reduce menopausal related issues Health problems lay the foundation for health in old age.

    Experts from the community and grass-roots branch of the Beijing Society of Obstetrics and Gynecology formulated the "Expert Consensus on Menopausal Women's Health Management (Grassroots Edition)" based on evidence-based medicine evidence, the status quo of primary medical institutions, and relevant guidelines for menopausal management.

    The health management of menopausal women mainly includes the establishment of health records, systematic health education, regular health check-ups, general health care guidance, and medications.

    The issuance of this consensus is of great significance to improving the health management of menopausal women in primary medical institutions.

    Recommended reading: Menopausal Syndrome-MHT treatment by primary-level doctors must follow these 6 principles.
    Download link: http://guide.
    medlive.
    cn/guideline/22688 Hyperthyroidism Syndrome Combined Diagnosis and Treatment Guide Hyperthyroidism ( Hyperthyroidism) referred to as "hyperthyroidism", is a group of clinical syndromes in which excessive secretion of thyroid hormone leads to increased excitability and hypermetabolism of the body.
    Graves disease is the most common type.

    This guide is organized and compiled by the Endocrinology and Metabolic Diseases Professional Committee of the Chinese Medical Physician Association of Integrative Medicine Physicians Branch.
    It is for clinicians to use as a reference when treating Graves' disease with a combination of disease and syndrome.
    Hyperthyroidism caused by other causes can also be treated with this guide.

    Download link: http://guide.
    medlive.
    cn/guideline/22696
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.